Common antibiotic could treat inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a...
adminph
AI tool helps find life-saving medicine for rare disease
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient...
Qureight and Avalyn launch strategic partnership in pulmonary fibrosis
Partnership aims to leverage cutting-edge technology in clinical trials Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership...
FDA grants Orphan Drug Designation to Ariceum cancer therapy
Designation follows promising preclinical data and FDA clearance Ariceum Therapeutics, a private biotech company based in Berlin, has announced that...
AI accelerates the search for new tuberculosis drug targets
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air...
Rippon Ubhi
Sanofi's Rippon Ubhi appointed new Chair of European Medicines Group Sanofi has announced that Rippon Ubhi has been appointed as the new Chair...
Novartis secures MHRA authorisation for ribociclib
Breast cancer therapy offers hope for patients at risk of recurrence Novartis UK announced the Medicines and Healthcare products Regulatory...
Omega-3s can slow down aging process
Many people would like to delay or even stop the aging process. Previous clinical studies have shown that a reduced...
Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies
Partnership aims to create recombinant nanobodies to treat immune disorders Grifols, a global healthcare company and leading manufacturer of plasma-derived...
Algiax announces results from phase 2a trial for neuropathic pain treatment
Study shows AP-325 offers lasting pain relief without central side effects Algiax Pharmaceuticals, a company committed to developing innovative treatments...
Cardiovascular disease medications underused globally
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to...
Aplagon secures EUR 7 million for APAC phase 2a trials
Funding led by new investors FSG and EIC Fund Helsinki-based Aplagon has raised EUR 7 million to advance its APAC...
CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients
Positive opinion issued for marketing authorisation extension The Committee for Medicinal Products for Human Use (CHMP) has recommended extending marketing...
Gene therapy may be “one shot stop” for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must...
Researchers identify genetic 'fingerprint' to predict drug resistance in bacteria
Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World...
Network of trust
How the emc supports the accessibility of medicines information Distributing reliable information about medicines is challenging for the pharma industry...
Research resolutions
Diversity remains high on the agenda for those designing and delivering clinical trials with the aim of bringing new treatments...
Harnessing generative AI to treat undruggable diseases
Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and...
Paula Sutherland
Alliance Healthcare has appointed Paula Sutherland as Sales Director Alliance Healthcare UK has announced that Paula Sutherland has been appointed to the position of Sales...
Janine Schuurman
Commit Biologics has appointed Janine Schuurman to its board Commit Biologics has announced the appointment of Janine Schuurman to its Board of Directors. Janine is...
